CANCER RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究 经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰 经验分享：能行吗肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究 经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省)]

2024-12-30 ms4000000265024223 来自山东省

偏重的研究方向：肿瘤基础研究
经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭

22 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究 经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰 经验分享：能行吗肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究 经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省)]

2025-04-09 ms8000000289511534 来自四川省

请问需要审稿费么？

7 0

[GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究 经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰 经验分享：能行吗肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究 经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省)]

2025-02-18 Mr.Never Die 来自上海

偏重的研究方向：蛋白质翻译后修饰
经验分享：能行吗肿瘤的蛋白ptm 能中吗

13 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究 经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰 经验分享：能行吗肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究 经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省)]

2025-01-16 dr_NEO 来自山东省

偏重的研究方向：肿瘤基础研究
经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭

20 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究 经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰 经验分享：能行吗肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究 经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省)]

2022-11-09 124af5c7m81暂无昵称

请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？

155 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究 经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰 经验分享：能行吗肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究 经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省)]

2024-04-28 147ce2ffm38(暂无昵称) 来自北京

编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平

176 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究 经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰 经验分享：能行吗肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究 经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省)]

2024-08-16 ms3000001981169340 来自上海

偏重的研究方向：肿瘤研究
经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？

98 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究 经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰 经验分享：能行吗肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究 经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省)]

2023-09-21 ms1000000959787142 来自天津

各位大佬们，这个杂志under editorial consideration 大概需要多久呀

176 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究 经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰 经验分享：能行吗肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究 经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省)]

2023-06-18 ms2000000311873048 来自湖南省

审稿速度:1.0
偏重的研究方向：肿瘤
经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧

194 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究 经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰 经验分享：能行吗肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究 经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省)]

2024-06-27 ms9000000416465180 来自广东省

偏重的研究方向：肿瘤基础研究;肿瘤
经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易

102 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务